Iambic Therapeutics, Inc. (IAM)
10.98
-0.66
(-5.67%)
USD |
NASDAQ |
Nov 06, 10:09
Iambic Therapeutics Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Korsana Biosciences, Inc. | 3.639 |
| IRulya Therapeutics, Inc. | -- |
| Erasca, Inc. | 11.41 |
| PepGen Inc. | 1.448 |
| Moderna, Inc. | 15.28 |
Price to Book Value Related Metrics
| Price | 10.98 |